ATE441711T1 - Peptide fähig die dimerisierung von c-jun zu inhibieren - Google Patents

Peptide fähig die dimerisierung von c-jun zu inhibieren

Info

Publication number
ATE441711T1
ATE441711T1 AT04712970T AT04712970T ATE441711T1 AT E441711 T1 ATE441711 T1 AT E441711T1 AT 04712970 T AT04712970 T AT 04712970T AT 04712970 T AT04712970 T AT 04712970T AT E441711 T1 ATE441711 T1 AT E441711T1
Authority
AT
Austria
Prior art keywords
peptides
jun
nucleic acid
dimerization
inhibit
Prior art date
Application number
AT04712970T
Other languages
English (en)
Inventor
Paul Watt
Wayne Thomas
Richard Hopkins
Original Assignee
Phylogica Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phylogica Ltd filed Critical Phylogica Ltd
Application granted granted Critical
Publication of ATE441711T1 publication Critical patent/ATE441711T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1082—Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT04712970T 2003-02-21 2004-02-20 Peptide fähig die dimerisierung von c-jun zu inhibieren ATE441711T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/372,003 US7270969B2 (en) 1999-05-05 2003-02-21 Methods of constructing and screening diverse expression libraries
PCT/AU2004/000214 WO2004074479A1 (en) 2003-02-21 2004-02-20 Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom

Publications (1)

Publication Number Publication Date
ATE441711T1 true ATE441711T1 (de) 2009-09-15

Family

ID=32907685

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04712970T ATE441711T1 (de) 2003-02-21 2004-02-20 Peptide fähig die dimerisierung von c-jun zu inhibieren

Country Status (6)

Country Link
US (4) US7270969B2 (de)
EP (2) EP1601766B1 (de)
AT (1) ATE441711T1 (de)
CA (2) CA2516284A1 (de)
DE (1) DE602004022922D1 (de)
WO (1) WO2004074479A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7323179B2 (en) * 1997-12-19 2008-01-29 Naomi Balaban Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections
US7803765B2 (en) * 1999-05-05 2010-09-28 Phylogica Limited Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom
US7270969B2 (en) * 1999-05-05 2007-09-18 Phylogica Limited Methods of constructing and screening diverse expression libraries
CA2372464C (en) 1999-05-05 2012-07-31 Phylogica Limited Isolating biological modulators from biodiverse gene fragment libraries
AU2004243340B2 (en) * 2003-05-30 2009-01-08 Phylogica Limited An improved genetic screen for interaction interface mapping
US20050032097A1 (en) * 2003-06-17 2005-02-10 Garvin Alex M. Method for processing samples containing sperm and non-sperm cells for subsequent analysis of the sperm DNA
KR100595864B1 (ko) * 2004-01-27 2006-06-30 재단법인 목암생명공학연구소 형질전환 사카로마이세스 세레비지애 균주 및 이를 이용한ｌｋ8 단백질의 생산방법
CA2568644C (en) * 2004-06-03 2015-11-24 Phylogica Limited Peptide modulators of cellular phenotype and bi-nucleic acid fragment library
CA2577995A1 (en) * 2004-08-20 2006-02-23 Phylogica Limited Peptide inhibitors of c-jun dimerization and uses thereof
DK1987178T3 (en) * 2006-02-20 2015-04-20 Phylogica Ltd Process for the construction and screening of peptide structure libraries
US8131348B2 (en) * 2006-05-12 2012-03-06 Northshore University Healthsystem Systems, methods and apparatuses of elastic light scattering spectroscopy and low coherence enhanced backscattering spectroscopy
CN101548153A (zh) * 2006-05-12 2009-09-30 西北大学 低相干增强背散射光谱的系统、方法和设备
AU2007281932B2 (en) * 2006-08-11 2013-07-25 Northshore University Healthsystem Method for identifying refractive-index fluctuations of a target
EP2080029B1 (de) 2006-08-31 2014-03-26 Nexigen GmbH Mittel und verfahren zum nachweis von protein-peptid-wechselwirkungen
US8063012B2 (en) 2006-09-19 2011-11-22 Phylogica Limited Neuroprotective peptide inhibitors of AP-1 signaling and uses therefor
US8822409B2 (en) * 2007-06-20 2014-09-02 Phylogica Limited Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ARDS) and clinical disorders associated with therewith
US20110262508A1 (en) 2007-11-07 2011-10-27 Paul Michael Watt Antimicrobial compositions, formulations and uses thereof
US9885834B2 (en) 2009-01-08 2018-02-06 Northwestern University Probe apparatus for measuring depth-limited properties with low-coherence enhanced backscattering
KR102231531B1 (ko) 2009-02-13 2021-03-23 엑스-켐, 인크. Ｄｎａ―코딩된 라이브러리의 생성 및 스크리닝 방법
US20120004137A1 (en) * 2009-02-13 2012-01-05 X-Body, Inc. Identification of nucleic acid delivery vehicles using dna display
CA2805653A1 (en) 2010-07-20 2012-01-26 Cephalon Australia Pty Ltd Anti-il-23 heterodimer specific antibodies
ES2675111T3 (es) 2011-09-07 2018-07-06 X-Chem, Inc. Métodos para etiquetar bibliotecas con codificación de ADN
MX2014003689A (es) 2011-09-30 2014-12-05 Teva Pharmaceuticals Australia Pty Ltd Anticuerpos contra tl1a y sus usos.
AU2012327878A1 (en) 2011-10-28 2014-05-29 Patrys Limited PAT-LM1 epitopes and methods for using same
US20150105274A1 (en) * 2012-02-10 2015-04-16 Phylogica Limited Methods for the Characterisation of Interaction Sites on Target Proteins
CN104685115A (zh) 2012-07-13 2015-06-03 X-化学有限公司 具有聚合酶不可读的编码性寡核苷酸连接的dna编码文库
PT2951208T (pt) 2013-02-01 2019-12-30 Univ California Anticorpos anti-cd83 e sua utilização
WO2014182574A1 (en) * 2013-05-04 2014-11-13 The Board Of Trustees Of The Leland Stanford Junior University Enrichment of dna sequencing libraries from samples containing small amounts of target dna
RU2718054C2 (ru) 2013-11-28 2020-03-30 СиЭсЭл ЛИМИТЕД Способ лечения нефропатии
CN105979965B (zh) 2013-12-18 2021-07-09 杰特有限公司 治疗伤口的方法
US9670485B2 (en) 2014-02-15 2017-06-06 The Board Of Trustees Of The Leland Stanford Junior University Partitioning of DNA sequencing libraries into host and microbial components
US9938522B2 (en) 2014-09-25 2018-04-10 Genewiz, Inc. High throughput sequencing of end regions of long linear DNAs
US10870704B2 (en) 2014-10-23 2020-12-22 Kira Biotech Pty Limited CD83 binding proteins and uses thereof
GB201522618D0 (en) 2015-12-22 2016-02-03 Phoremost Ltd Methods of screening
CN116217657A (zh) 2016-05-27 2023-06-06 辛赛克斯公司 蛋白质界面
AU2017331739A1 (en) 2016-09-23 2019-03-07 Csl Limited Coagulation factor binding proteins and uses thereof
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
EP3545000A4 (de) 2016-11-22 2020-07-08 DendroCyte BioTech Pty Ltd Anti-cd300f-antikörper und verwendungen davon
MX2019006866A (es) 2016-12-16 2019-08-22 Merck Patent Gmbh Metodos para el uso de proteina de enlace a galectina 3 detectada en la orina para supervisar la gravedad y el progreso de nefritis lupica.
WO2019104244A1 (en) 2017-11-22 2019-05-31 Synthex, Inc. Peptides for inhibiting rad51
CN110453000A (zh) * 2019-08-15 2019-11-15 深圳谱元科技有限公司 一种用于鉴定样品中幽门螺杆菌的细菌分型和耐药类型的二代测序建库方法
US11351238B2 (en) 2019-10-16 2022-06-07 The Florida International University Board Of Trustees Vaccines against malaria transmission
JP7807372B2 (ja) 2019-12-20 2026-01-27 ハドソン インスティチュート オブ メディカル リサーチ Ｃｘｃｌ１０結合タンパク質及びその使用
EP4110467A4 (de) * 2020-03-31 2024-03-27 The Administrators of the Tulane Educational Fund Antivirale peptide mit breitem spektrum
WO2022015934A2 (en) * 2020-07-15 2022-01-20 The Johns Hopkins Universtiy Comprehensive analysis of anti-allergen antibodies using phage display
CN112400807A (zh) * 2020-09-10 2021-02-26 中国科学院动物研究所 一种基于传粉昆虫壁蜂采集植物花粉的种类与数量鉴定方法
JPWO2022154121A1 (de) * 2021-01-18 2022-07-21

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US645563A (en) 1899-07-06 1900-03-20 Mark L Heath Pocket-knife.
DE68926118T2 (de) 1988-08-18 1996-08-22 Australian Membrane And Biotechnology Research Institute Ltd. Commonwealth Scientific And Industrial Research Organization, North Ryde, Neusuedwales Verbesserungen an der empfindlichkeit und der selektivität von ionenkanalmembranbiosensoren
AU623747B2 (en) 1989-01-27 1992-05-21 Ambri Limited Receptor membranes and ionophore gating
US5356773A (en) * 1989-05-16 1994-10-18 Kinetic Investments Limited Generation of unidirectional deletion mutants
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
ATE449853T1 (de) 1990-02-01 2009-12-15 Siemens Healthcare Diagnostics HERSTELLUNG UND VERWENDUNG VON GENBANKEN MENSCHLICHER ANTIKÖRPER(ßHUMAN-ANTIKÖRPER- BIBLIOTHEKENß)
ES2113940T3 (es) 1990-12-03 1998-05-16 Genentech Inc Metodo de enriquecimiento para variantes de proteinas con propiedades de union alteradas.
AU689755B2 (en) 1992-09-22 1998-04-09 Biofocus Discovery Limited Recombinant viruses displaying a nonviral polypeptide on their external surface
US5834247A (en) * 1992-12-09 1998-11-10 New England Biolabs, Inc. Modified proteins comprising controllable intervening protein sequences or their elements methods of producing same and methods for purification of a target protein comprised by a modified protein
US6521425B2 (en) * 1997-03-05 2003-02-18 New England Biolabs, Inc. Screening and use of reagents which block or activate intein splicing utilizing natural or homologous exteins
US5470953A (en) 1993-12-23 1995-11-28 Icos Corporation Human β2 integrin α subunit
US5525490A (en) 1994-03-29 1996-06-11 Onyx Pharmaceuticals, Inc. Reverse two-hybrid method
US5516637A (en) 1994-06-10 1996-05-14 Dade International Inc. Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
US20030215798A1 (en) 1997-06-16 2003-11-20 Diversa Corporation High throughput fluorescence-based screening for novel enzymes
US6238884B1 (en) 1995-12-07 2001-05-29 Diversa Corporation End selection in directed evolution
US5783431A (en) 1996-04-24 1998-07-21 Chromaxome Corporation Methods for generating and screening novel metabolic pathways
US6699658B1 (en) 1996-05-31 2004-03-02 Board Of Trustees Of The University Of Illinois Yeast cell surface display of proteins and uses thereof
US5763239A (en) 1996-06-18 1998-06-09 Diversa Corporation Production and use of normalized DNA libraries
US5955275A (en) * 1997-02-14 1999-09-21 Arcaris, Inc. Methods for identifying nucleic acid sequences encoding agents that affect cellular phenotypes
US5846722A (en) 1996-10-16 1998-12-08 Terrapin Technologies, Inc. System to detect small molecule/peptide interaction
US6326204B1 (en) * 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
US6403370B1 (en) 1997-02-10 2002-06-11 Genstar Therapeutics Corporation Oncolytic/immunogenic complementary-adenoviral vector system
GB9703406D0 (en) 1997-02-19 1997-04-09 Chiron Spa Expression of heterologous proteins
US6720413B1 (en) * 1997-03-04 2004-04-13 Musc Foundation For Research Development Methods and compositions for diagnosis and treatment of cancer
CA2294080A1 (en) 1997-06-04 1998-12-10 Australian Membrane And Biotechnology Research Institute Improved biosensor involving the use of optically sensitive moieties
US6083715A (en) 1997-06-09 2000-07-04 Board Of Regents, The University Of Texas System Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
US6583275B1 (en) 1997-07-02 2003-06-24 Genome Therapeutics Corporation Nucleic acid sequences and expression system relating to Enterococcus faecium for diagnostics and therapeutics
US20030191301A1 (en) * 1997-12-29 2003-10-09 Juan F. Medrano Cloning of a high growth gene
US6436694B1 (en) * 1998-01-09 2002-08-20 Cubist Pharmaceuticals, Inc. Regulable gene expression in gram-positive bacteria
US6475726B1 (en) * 1998-01-09 2002-11-05 Cubist Pharmaceuticals, Inc. Method for identifying validated target and assay combinations for drug development
US6846625B1 (en) * 1998-01-09 2005-01-25 Cubist Pharmaceuticals, Inc. Method for identifying validated target and assay combination for drug development
DE69935313T2 (de) 1998-01-09 2007-11-15 Phylogica Ltd., Northbridge Nachweisverfahren für peptide
US6316223B1 (en) 1998-03-30 2001-11-13 Rigel Pharmaceuticals, Inc. Mammalian protein interaction cloning system
US6225530B1 (en) * 1998-04-15 2001-05-01 The Salk Institute For Biological Studies Flowering locus T (FT) and genetically modified plants having modulated flower development
US6190908B1 (en) 1998-08-12 2001-02-20 The Scripps Research Institute Modulation of polypeptide display on modified filamentous phage
US7315786B2 (en) * 1998-10-16 2008-01-01 Xencor Protein design automation for protein libraries
US6720139B1 (en) * 1999-01-27 2004-04-13 Elitra Pharmaceuticals, Inc. Genes identified as required for proliferation in Escherichia coli
US7803765B2 (en) * 1999-05-05 2010-09-28 Phylogica Limited Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom
CA2372464C (en) * 1999-05-05 2012-07-31 Phylogica Limited Isolating biological modulators from biodiverse gene fragment libraries
US7270969B2 (en) * 1999-05-05 2007-09-18 Phylogica Limited Methods of constructing and screening diverse expression libraries
KR100379411B1 (ko) 1999-06-28 2003-04-10 엘지전자 주식회사 바이오칩 및 그의 생체 물질 패터닝 및 측정 방법
US6560542B1 (en) * 2000-01-24 2003-05-06 The Cielo Institute Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins
US6523392B2 (en) 2000-01-25 2003-02-25 Arizona Board Of Regents Microcantilever sensor
JP4425420B2 (ja) 2000-04-03 2010-03-03 独立行政法人理化学研究所 マイクロアレイ作製装置
WO2002004685A1 (en) 2000-07-12 2002-01-17 California Institute Of Technology Method for determining three-dimensional protein structure from primary protein sequence
US20020102617A1 (en) 2000-08-03 2002-08-01 Macbeath Gavin Protein microarrays
US6962798B2 (en) * 2000-12-21 2005-11-08 Board Of Regents, The University Of Texas System Methods and compositions relating to a cardiac-specific nuclear regulatory factor
EP1363714B1 (de) 2001-02-20 2012-10-10 Advion BioSystems, Inc. Mikrochip-elektrosprayvorrichtung und säule mit affinitätsadsorptionsmitteln und ihre verwendung
US7117096B2 (en) * 2001-04-17 2006-10-03 Abmaxis, Inc. Structure-based selection and affinity maturation of antibody library
US20020192654A1 (en) 2001-06-15 2002-12-19 Tao-Kuang Chang Bio-chip substrate for the embedding of DNA or protein and its fabrication method
EP1277835A1 (de) * 2001-07-19 2003-01-22 Libragen Methoden um genetische vielfalt zu kreieren
CA2577995A1 (en) 2004-08-20 2006-02-23 Phylogica Limited Peptide inhibitors of c-jun dimerization and uses thereof
DK1987178T3 (en) * 2006-02-20 2015-04-20 Phylogica Ltd Process for the construction and screening of peptide structure libraries

Also Published As

Publication number Publication date
US20120178649A1 (en) 2012-07-12
CA2516284A1 (en) 2004-09-02
US20030215846A1 (en) 2003-11-20
EP2175022A1 (de) 2010-04-14
EP1601766A4 (de) 2006-09-06
EP1601766A1 (de) 2005-12-07
US20150232835A1 (en) 2015-08-20
US7270969B2 (en) 2007-09-18
EP1601766B1 (de) 2009-09-02
DE602004022922D1 (de) 2009-10-15
WO2004074479A1 (en) 2004-09-02
US20090170722A1 (en) 2009-07-02
CA2714863A1 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
DE602004022922D1 (de) Peptide fähig die Dimerisierung von c-Jun zu inhibieren
CY1123400T1 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
DK1534830T3 (da) In vito-peptid-ekspressionsbibliotek
CY1109715T1 (el) IL-1β ΔΕΣΜΕΥΤΙΚΑ ΑΝΤΙΣΩΜΑΤΑ ΚΑΙ ΘΡΑΥΣΜΑΤΑ ΑΥΤΩΝ
EA200801621A1 (ru) Антитела, направленные на her-3, и их применение
DK1392359T4 (da) Specifikke bindingsproteiner og deres anvendelser.
ATE441715T1 (de) Streptococcus pyogenes antigene
EP1688488A4 (de) Biospezifischer antikörper als ersatz für funktionelle proteine
WO2003000842A3 (en) Novel proteins and nucleic acids encoding same
JO3244B1 (ar) بروتينات ربط مستضادات il – 23 البشرية
WO2005017205A3 (en) Nucleic acid mapping using linear analysis
WO2002095051A3 (en) Mage-a3 peptides presented by hla class ii molecules
WO2005030793A3 (en) Antibodies which bind human cxcr3
WO2004113500A3 (en) B7s1: an immune modulator
EA200801174A1 (ru) Антитела-миметики glp-2, полипептиды, композиции, способы и применения
WO2004087874A3 (en) Novel nucleic acids and polypeptides
WO2002081498A3 (en) Novel proteins and nucleic acids encoding same
WO2003010327A3 (en) Novel proteins and nucleic acids encoding same
IL169804A (en) 254p1d6b proteins, nucleic acids encoding the same, processes for producing the same, antibodies binding thereto and uses thereof
ATE449177T1 (de) Staphylococcus epidermidis antigene
WO2001066752A3 (en) Reproduction-specific genes
WO2002072757A3 (en) Novel proteins and nucleic acids encoding same
WO2006046042A3 (en) Method of selecting polypeptides
WO2004087886A3 (en) Modified adenoviral e1a constructs and methods of use thereof
WO2005023979A3 (en) Isolated s. mansoni nucleic acid molecules and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties